To assess its ability to cure LPS-induced depression-like behavior, IGF-I was administered i.c.v. 24 h after i.p. LPS (when sickness behavior was expected to be mild or absent; thereby testing for an antidepressant activity of IGF-I following acute sickness). Here, IGF1 is linked to major depressive disorder.